(((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-6-(MethoxyMethoxy)-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy))bis(tert-butyldiMethylsilane)
医药中间体 · — · —
医药中间体Confidentiality：公开
- INN / Generic Name
- (((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-6-(MethoxyMethoxy)-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy))bis(tert-butyldiMethylsilane)
- CAS No.
- 1435939-17-5
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Paricalcitol
- Current Status
- 官方中间体目录（API: Paricalcitol）
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO 供货（非注册物质）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —